Investors / Italy / Claris Ventures
Claris Ventures
Venture capital · Turin, Italy · Europe
Claris Ventures is an Italian alternative investment fund manager (SGR) founded in 2019 that invests exclusively in companies developing new medicines. It backs existing early-stage therapeutics companies and also creates new biotech companies around academic science.
Invests inHealthcare & Biotech
In its own wordstherapeuticsbiotechdrug developmentlife sciencescompany creationearly stage
Your fit with Claris Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsClaris Ventures lists 10 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 100% of its companies are based in Italy. It invests most often alongside CDP Venture Capital, Indaco Venture Partners SGR and 3B Future Health Fund.
No funding round on record names Claris Ventures yet, so the figures come from its portfolio page.
Round figures show recent activity, not Claris Ventures' whole history. Rounds on record name 0 companies; its own site lists 10. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 23th | 10 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 19th | 1 country |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers10100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with CDP Venture Capital
Compare Claris Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
10 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| ALKemist Bio is developing novel immuno-therapies to recognize the ALK oncogene and eliminate ALK-positive cancer cells | Healthcare & Biotech | Portfolio page | ||
| Haptena Therapeutics is a biotech company that advances next-generation immunotherapies for genetically defined cancers. | Healthcare & Biotech | Portfolio page | ||
| Heqet Therapeutics develops first-in-class non-coding RNA-based compounds to address highly unmet medical needs in acute myocardial infarction and other cardiovascular diseases. | Healthcare & Biotech | Portfolio page | ||
| IAMA Therapeutics is developing treatments to support individuals with neurologic conditions | Healthcare & Biotech | Portfolio page | ||
| Kither Biotech is a clinical-stage biotech company dedicated to developing innovative cell signal transduction modulators delivered directly to the lung for the treatment of several respiratory diseases. | Healthcare & Biotech | Portfolio page | ||
| Lever Bio focuses on reprogramming the solid tumor microenvironment to foster anti-cancer immune response | Healthcare & Biotech | Portfolio page | ||
| NeoPhore develops a therapeutic approach that blocks DNA Mismatch Repair to make tumors sensitive to immunotherapy. | Healthcare & Biotech | Portfolio page | ||
| PAGE Therapeutics is a platform-based oncology drug development company. | Healthcare & Biotech | Portfolio page | ||
| Resalis Therapeutics is dedicated to developing RNA-based therapies that tackle the root causes of complex metabolic disorders. | Healthcare & Biotech | Portfolio page | ||
| Sibylla Biotech develops small molecule drug candidates that target proteins before they become undruggable using its proprietary technology platform. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- clarisventures.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Companies checked
- 10
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Claris Ventures' profile as data
Pull Claris Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/clarisventures.com
# also
GET /v1/firms/clarisventures.com/portfolio
GET /v1/firms/clarisventures.com/coinvestors
GET /v1/firms/clarisventures.com/news